Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02299388 · ClinicalTrials.gov registry record · Phase 4

To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study

A Phase 4 study of Diabetes Mellitus, Non-Insulin-Dependent and Hypertensive Disease, sponsored by Tulane University School of Medicine.

Completed
Registry status
Phase 4
Development phase
11
Enrollment target
1
Study location

NCT02299388 is a Phase 4 study of Diabetes Mellitus, Non-Insulin-Dependent and Hypertensive Disease that has completed, run by Tulane University School of Medicine. The registered enrollment target is 11 participants, below the 242-participant average among 5 other Diabetes Mellitus, Non-Insulin-Dependent trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02299388, a Phase 4 study of Diabetes Mellitus, Non-Insulin-Dependent and Hypertensive Disease, has completed, sponsored by Tulane University School of Medicine.

COMPLETED
Registry status
Phase 4
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The investigators are conducting this research to study the effect of Liraglutide on blood pressure. Several studies have shown increased cardiovascular complications and deaths in diabetics with hypertension. The importance of blood pressure control in diabetes has been shown in many clinical trials. No drug already approved for treating Type 2 Diabetes Mellitus is known to reduce blood pressure along with improving diabetes. However, prior research studies with liraglutide have suggested that treatment with liraglutide improves blood pressure. This effect is seen very quickly and even prior to any weight loss. The mechanism behind this effect is yet to be determined.

Conditions Studied

Diabetes Mellitus, Non-Insulin-Dependent Hypertensive Disease

Interventions

  • DRUG Liraglutide or Placebo

Study Locations (1)

Louisiana

  • Tulane University Health Science Center, Tidewater building and Tulane Hospital and Clinics - New Orleans

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2014-10
Est. Completion 2016-12
Phase Phase 4

Sponsor

Tulane University School of Medicine

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02299388

The ClinicalTrials.gov registry entry for NCT02299388 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 5 other Diabetes Mellitus, Non-Insulin-Dependent trials with a reported enrollment target (95% lower). The listed sponsor is Tulane University School of Medicine, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus, Non-Insulin-Dependent appearing as the primary indexed condition, and to 1 intervention - of which Liraglutide or Placebo is the first listed.

NCT02299388 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT02299388 about?

NCT02299388 is a clinical study titled "To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study". The investigators are conducting this research to study the effect of Liraglutide on blood pressure. Several studies have shown increased cardiovascular complications and deaths in diabetics with hypertension. The importance of blood pressure control in diabetes has been shown in many clinical trial...

What is the current status of trial NCT02299388?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2014-10. Estimated completion is 2016-12.

What conditions does trial NCT02299388 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Non-Insulin-Dependent, Hypertensive Disease.

What interventions are being tested in trial NCT02299388?

The interventions under investigation include: Liraglutide or Placebo (DRUG).

Who is sponsoring clinical trial NCT02299388?

This trial is sponsored by Tulane University School of Medicine, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02299388 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Non-Insulin-Dependent

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Non-Insulin-Dependent

All registered trials for this condition

Hypertensive Disease

All registered trials for this condition

Louisiana

All trials with a study site in Louisiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.